Galenica refines long-term health strategy, shares anchored on SIX Swiss Exchange

Galenica outlines its role in Switzerland’s healthcare system with a broad network of pharmacies and services, while its shares trade on the SIX Swiss Exchange as investors track the group’s long-term strategy.

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-29, 11:35.

Galenica (CH0025536027) shapes a broad-based healthcare network in Switzerland through pharmacies, logistics and health services. Its shares trade on the SIX Swiss Exchange, where investors follow the group’s long-term strategy and defensive healthcare positioning.

Integrated Swiss healthcare network

Galenica describes itself as the operator of the Galenica network with more than 20 business units that cooperate with strong partners in the Swiss healthcare market. This network spans retail pharmacies, wholesale distribution, health services and related solutions across the country, according to the company’s website. The Galenica group overview shows the breadth of the business units and their focus areas.

The company emphasizes that its ambition is to meet patient and customer needs in the Swiss healthcare market in a seamless, powerful and personal way. This positioning underlines Galenica’s role as a central player in Switzerland’s health infrastructure, which tends to be viewed as a structurally stable sector by many investors. The network approach aims to create efficiencies between retail, logistics and service offerings within the Galenica ecosystem.

Strategic focus and business pillars

At group level, Galenica’s strategy rests on several pillars, including expansion and optimization of its pharmacy network, further development of its wholesale and logistics capabilities and the scaling of healthcare services and digital solutions. The company highlights that these pillars are designed to support sustainable growth in the Swiss market over the long term, building on its existing footprint and partnerships. The investor relations section provides additional context on the strategic priorities and financial targets.

Galenica’s pharmacy brands form a key element of its strategy, aiming to provide nationwide access points for patients and consumers. Alongside brick-and-mortar locations, the group also develops digital channels and health services that can complement traditional pharmacy visits. The logistics and wholesale activities are intended to ensure reliable supply of medicines and health products across Switzerland, connecting manufacturers with pharmacies and other healthcare providers.

The product behind the stock

One representative element of Galenica’s business is its network of pharmacies operating under brands such as Amavita and Sun Store, which are part of the Galenica group in Switzerland. These pharmacies provide prescription medicines, over-the-counter products, health advice and related services to patients and consumers at numerous locations across the country, forming a visible interface between the group and end customers. The Galenica network presentation lists the main retail brands and their positioning.

Where the shares trade today

The Galenica shares (CH0025536027) trade on 2026-06-29, 10:07 on the SIX Swiss Exchange at 85.75 Swiss francs, based on the latest quote on the company’s website.

Key data on the Galenica shares

• Company: Galenica AG
• ISIN: CH0025536027
• WKN: 552300
• Ticker: GALE
• Trading venue: SIX Swiss Exchange
• Price (as of 2026-06-29, 10:07): 85.75 CHF
• Market cap: 4.47 billion CHF (as of 2026-06-29)
• Sector / industry: Health Care / Health Care Providers & Services
• Index membership: SPI, SPI Extra
• Next earnings date: not officially scheduled

Disclaimer: This article is for informational purposes only and does not constitute investment advice, investment recommendation or an offer or solicitation to buy or sell any financial instrument. Investors should conduct their own research and, where appropriate, consult a qualified financial adviser before making investment decisions.